Document is current
Any future updates will be listed below
-
Authors
Manconi, Mauro
Garcia-Borreguero, Diego
Schormair, Barbara
Videnovic, Aleksandar https://orcid.org/0000-0002-9237-1516
Berger, Klaus
Ferri, Raffaele https://orcid.org/0000-0001-6937-3065
Dauvilliers, Yves
- License Information
-
More Information
Article History
Accepted: 22 September 2021
First Online: 3 November 2021
Competing interests
: Y.D. participated on the advisory boards for UCB Pharma, Jazz, Theranexus, Avadel, Idorsia, Takeda, and Bioprojet, outside this work. K.B. has received, for a study on the ‘Course of Restless Legs Syndrome’ (2008–2014), unrestricted grants to the University of Muenster from the German Restless Legs Society and a consortium with equal shares formed by Boehringer Ingelheim Pharma, Mundipharma Research, Neurobiotec, UCB Germany and Switzerland, Vifor Pharma and Roche Pharma. M.M. participated on the advisory boards of Jazz and Avadel, and also received an unrestricted grant from Vifor Pharma and Philips Respironics for the “Life-ON Study” to explore sleep disorders during pregnancy. R.F. participated in educational activities for Jazz. B.S. has received research funding from the German Restless Legs Society and has filed a patent application. D.G.-B. has received research grants from MSDS and Roche, and has consulted for Roche, Idorsia, Luye Pharma, Takeda and American Regent. A.V. declares no competing interests.
